Medtronic plc is sponsoring a randomized trial to evaluate the ability of a new algorithm for the Reveal LINQ insertable cardiac monitor to identify patients at high risk of worsening heart failure.
Reveal LINQ is a monitor about one-third the size of a AAA battery that is inserted just beneath the skin through a small incision in the upper left side of the chest